Twentyeight-Seven Therapeutics

About:

Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.

Website: https://www.twentyeight-seven.com/

Top Investors: Vertex Ventures, Longwood Fund, OUP (Osage University Partners), Novartis Venture Fund, MPM Capital

Description:

Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.The company's modulating RNA which are short non-coding RNAs that inhibit target gene expression by suppressing mRNA translation and promoting mRNA decay and develop small molecules that can modulate levels of miRNAs by targeting proteins that interact with these miRNAs, enabling users to target miRNAs are directly involved in cancer initiation, progression, and metastasis.